Click here to get full coverage on MNMD Stock Up More Than 100% in 6 Months: What's in Store for 2026? - Yahoo Finance

MNMD Stock Up More Than 100% in 6 Months: What's in Store for 2026?  Yahoo Finance

MNMD Stock Up More Than 100% in 6 Months: What's in Store for 2026? - Yahoo Finance

Click here to get full coverage on Mind Medicine Inc. (MNMD) Stock Analysis: Exploring Potential Upside in a Transformative Biotech - DirectorsTalk Interviews

Mind Medicine Inc. (MNMD) Stock Analysis: Exploring Potential Upside in a Transformative Biotech  DirectorsTalk Interviews

Mind Medicine Inc. (MNMD) Stock Analysis: Exploring Potential Upside in a Transformative Biotech - DirectorsTalk Interviews

Click here to get full coverage on $MNMD stock is down 10% today. Here's what we see in our data. - Quiver Quantitative

$MNMD stock is down 10% today. Here's what we see in our data.  Quiver Quantitative

$MNMD stock is down 10% today. Here's what we see in our data. - Quiver Quantitative

Click here to get full coverage on Brain health biotech anticipates 3 Phase 3 readouts after JP Morgan talk - Stock Titan

Brain health biotech anticipates 3 Phase 3 readouts after JP Morgan talk  Stock Titan

Brain health biotech anticipates 3 Phase 3 readouts after JP Morgan talk - Stock Titan

Click here to get full coverage on MindMed (MNMD) Options Delisting on January 15th - GuruFocus

MindMed (MNMD) Options Delisting on January 15th  GuruFocus

MindMed (MNMD) Options Delisting on January 15th - GuruFocus

Click here to get full coverage on Does Mind Medicine MindMed (MNMD) Have the Potential to Rally 279.84% as Wall Street Analysts Expect? - MSN

Does Mind Medicine MindMed (MNMD) Have the Potential to Rally 279.84% as Wall Street Analysts Expect?  MSN

Does Mind Medicine MindMed (MNMD) Have the Potential to Rally 279.84% as Wall Street Analysts Expect? - MSN

Click here to get full coverage on MNMD Stock Up More Than 100% in 6 Months: What's in Store for 2026? - Zacks Investment Research

MNMD Stock Up More Than 100% in 6 Months: What's in Store for 2026?  Zacks Investment Research

MNMD Stock Up More Than 100% in 6 Months: What's in Store for 2026? - Zacks Investment Research

Click here to get full coverage on Assessing Mind Medicine (MNMD) Valuation After A Strong Year Of Share Price Momentum - Yahoo Finance

Assessing Mind Medicine (MNMD) Valuation After A Strong Year Of Share Price Momentum  Yahoo Finance

Assessing Mind Medicine (MNMD) Valuation After A Strong Year Of Share Price Momentum - Yahoo Finance

Click here to get full coverage on Mind Medicine (MNMD) Stock Analysis: Exploring the 99.75% Potential Upside in the Biotech Sector - DirectorsTalk Interviews

Mind Medicine (MNMD) Stock Analysis: Exploring the 99.75% Potential Upside in the Biotech Sector  DirectorsTalk Interviews

Mind Medicine (MNMD) Stock Analysis: Exploring the 99.75% Potential Upside in the Biotech Sector - DirectorsTalk Interviews

Click here to get full coverage on New Analyst Forecast: $MNMD Given $28.0 Price Target | MNMD Stock News - Quiver Quantitative

New Analyst Forecast: $MNMD Given $28.0 Price Target | MNMD Stock News  Quiver Quantitative

New Analyst Forecast: $MNMD Given $28.0 Price Target | MNMD Stock News - Quiver Quantitative

Click here to get full coverage on Assessing Mind Medicine (MNMD)’s Valuation After Strong Multi‑Year Share Price Gains - Yahoo Finance

Assessing Mind Medicine (MNMD)’s Valuation After Strong Multi‑Year Share Price Gains  Yahoo Finance

Assessing Mind Medicine (MNMD)’s Valuation After Strong Multi‑Year Share Price Gains - Yahoo Finance

Click here to get full coverage on Mind Medicine (MNMD) Stock Analysis: A Biotech Bet With 90.86% Potential Upside - DirectorsTalk Interviews

Mind Medicine (MNMD) Stock Analysis: A Biotech Bet With 90.86% Potential Upside  DirectorsTalk Interviews

Mind Medicine (MNMD) Stock Analysis: A Biotech Bet With 90.86% Potential Upside - DirectorsTalk Interviews

Click here to get full coverage on MindMed (MNMD): Evaluating Valuation After Recent Share Price Momentum Cools - Yahoo Finance

MindMed (MNMD): Evaluating Valuation After Recent Share Price Momentum Cools  Yahoo Finance

MindMed (MNMD): Evaluating Valuation After Recent Share Price Momentum Cools - Yahoo Finance

Click here to get full coverage on What’s Driving JonesTrading’s Bullish View on Mind Medicine (MindMed) Inc. (MNMD) - Yahoo Finance

What’s Driving JonesTrading’s Bullish View on Mind Medicine (MindMed) Inc. (MNMD)  Yahoo Finance

What’s Driving JonesTrading’s Bullish View on Mind Medicine (MindMed) Inc. (MNMD) - Yahoo Finance

Click here to get full coverage on Mind Medicine (MindMed) Inc.'s (NASDAQ:MNMD) high institutional ownership speaks for itself as stock continues to impress, up 26% over last week - Yahoo Finance

Mind Medicine (MindMed) Inc.'s (NASDAQ:MNMD) high institutional ownership speaks for itself as stock continues to impress, up 26% over last week  Yahoo Finance

Mind Medicine (MindMed) Inc.'s (NASDAQ:MNMD) high institutional ownership speaks for itself as stock continues to impress, up 26% over last week - Yahoo Finance

Click here to get full coverage on Why Mind Medicine (MNMD) Is Up 8.2% After $225M Equity Raise to Fund R&D and Acquisitions - Yahoo Finance

Why Mind Medicine (MNMD) Is Up 8.2% After $225M Equity Raise to Fund R&D and Acquisitions  Yahoo Finance

Why Mind Medicine (MNMD) Is Up 8.2% After $225M Equity Raise to Fund R&D and Acquisitions - Yahoo Finance

Click here to get full coverage on MindMed (MNMD): Assessing Valuation After MM120’s Breakthrough Results and Phase 3 Advances - Yahoo Finance

MindMed (MNMD): Assessing Valuation After MM120’s Breakthrough Results and Phase 3 Advances  Yahoo Finance

MindMed (MNMD): Assessing Valuation After MM120’s Breakthrough Results and Phase 3 Advances - Yahoo Finance

Click here to get full coverage on If You'd Invested $1,000 in Mind Medicine (MNMD) Stock 5 Years Ago, Here's How Much You'd Have Today - Yahoo Finance

If You'd Invested $1,000 in Mind Medicine (MNMD) Stock 5 Years Ago, Here's How Much You'd Have Today  Yahoo Finance

If You'd Invested $1,000 in Mind Medicine (MNMD) Stock 5 Years Ago, Here's How Much You'd Have Today - Yahoo Finance

Click here to get full coverage on Mind Medicine Inc (MNMD) Q3 2025 Earnings Call Highlights: Strategic Advances and Financial ... - Yahoo Finance

Mind Medicine Inc (MNMD) Q3 2025 Earnings Call Highlights: Strategic Advances and Financial ...  Yahoo Finance

Mind Medicine Inc (MNMD) Q3 2025 Earnings Call Highlights: Strategic Advances and Financial ... - Yahoo Finance

Click here to get full coverage on Mind Medicine (MindMed) Inc. (MNMD)’s MM120 Earns FDA Breakthrough Status in Anxiety Treatment - Yahoo Finance

Mind Medicine (MindMed) Inc. (MNMD)’s MM120 Earns FDA Breakthrough Status in Anxiety Treatment  Yahoo Finance

Mind Medicine (MindMed) Inc. (MNMD)’s MM120 Earns FDA Breakthrough Status in Anxiety Treatment - Yahoo Finance

Click here to get full coverage on Mind Medicine (MindMed) Inc.'s (NASDAQ:MNMD) large institutional owners must be happy as stock continues to impress, up 17% over the past week - simplywall.st

Mind Medicine (MindMed) Inc.'s (NASDAQ:MNMD) large institutional owners must be happy as stock continues to impress, up 17% over the past week  simplywall.st

Mind Medicine (MindMed) Inc.'s (NASDAQ:MNMD) large institutional owners must be happy as stock continues to impress, up 17% over the past week - simplywall.st

Click here to get full coverage on Mind Medicine (MindMed) Stock (MNMD) Opinions on Psychedelic Therapy Political Momentum - Quiver Quantitative

Mind Medicine (MindMed) Stock (MNMD) Opinions on Psychedelic Therapy Political Momentum  Quiver Quantitative

Mind Medicine (MindMed) Stock (MNMD) Opinions on Psychedelic Therapy Political Momentum - Quiver Quantitative

Click here to get full coverage on Mind Medicine (MNMD) Stock Analysis: A Biotech Bet With 90% Upside Potential - DirectorsTalk Interviews

Mind Medicine (MNMD) Stock Analysis: A Biotech Bet With 90% Upside Potential  DirectorsTalk Interviews

Mind Medicine (MNMD) Stock Analysis: A Biotech Bet With 90% Upside Potential - DirectorsTalk Interviews

Click here to get full coverage on Will Mind Medicine (MindMed) (MNMD)'s Fresh Capital Shape a New Phase of Strategic Ambitions? - Sahm

Will Mind Medicine (MindMed) (MNMD)'s Fresh Capital Shape a New Phase of Strategic Ambitions?  Sahm

Will Mind Medicine (MindMed) (MNMD)'s Fresh Capital Shape a New Phase of Strategic Ambitions? - Sahm

Click here to get full coverage on The Technical Signals Behind (MNMD) That Institutions Follow - Stock Traders Daily

The Technical Signals Behind (MNMD) That Institutions Follow  Stock Traders Daily

The Technical Signals Behind (MNMD) That Institutions Follow - Stock Traders Daily

Click here to get full coverage on Mind Medicine Inc (MNMD) Q2 2025 Earnings Call Highlights: Strategic Advances and Financial ... - Yahoo Finance

Mind Medicine Inc (MNMD) Q2 2025 Earnings Call Highlights: Strategic Advances and Financial ...  Yahoo Finance

Mind Medicine Inc (MNMD) Q2 2025 Earnings Call Highlights: Strategic Advances and Financial ... - Yahoo Finance

Click here to get full coverage on Anxious Times Ahead: MNMD's Pipeline Nears Its Make-or-Break Test In 2026 - RTTNews

Anxious Times Ahead: MNMD's Pipeline Nears Its Make-or-Break Test In 2026  RTTNews

Anxious Times Ahead: MNMD's Pipeline Nears Its Make-or-Break Test In 2026 - RTTNews

Click here to get full coverage on Mind Medicine (MNMD) Stock Analysis: A Biotech Play With A 90% Potential Upside - DirectorsTalk Interviews

Mind Medicine (MNMD) Stock Analysis: A Biotech Play With A 90% Potential Upside  DirectorsTalk Interviews

Mind Medicine (MNMD) Stock Analysis: A Biotech Play With A 90% Potential Upside - DirectorsTalk Interviews

Click here to get full coverage on Definium points the way forward as MindMed drops old identity - Fierce Pharma

Definium points the way forward as MindMed drops old identity  Fierce Pharma

Definium points the way forward as MindMed drops old identity - Fierce Pharma

Click here to get full coverage on MNMD: Mind Medicine Inc - Ordinary Shares (Sub Voting) Latest Stock Price, Analysis, News and Trading Ideas - Stocktwits

MNMD: Mind Medicine Inc - Ordinary Shares (Sub Voting) Latest Stock Price, Analysis, News and Trading Ideas  Stocktwits

MNMD: Mind Medicine Inc - Ordinary Shares (Sub Voting) Latest Stock Price, Analysis, News and Trading Ideas - Stocktwits

Click here to get full coverage on 28,000-Share Option: MindMed Grants Employee Inducement; 25% Vests After 1 Year, 4-year Schedule - Stock Titan

28,000-Share Option: MindMed Grants Employee Inducement; 25% Vests After 1 Year, 4-year Schedule  Stock Titan

28,000-Share Option: MindMed Grants Employee Inducement; 25% Vests After 1 Year, 4-year Schedule - Stock Titan

Click here to get full coverage on Mind Medicine Inc. will Change its Ticker to DFTX from MNMD - marketscreener.com

Mind Medicine Inc. will Change its Ticker to DFTX from MNMD  marketscreener.com

Mind Medicine Inc. will Change its Ticker to DFTX from MNMD - marketscreener.com

Click here to get full coverage on 1 Reason to Buy MindMed (MNMD) - The Motley Fool

1 Reason to Buy MindMed (MNMD)  The Motley Fool

1 Reason to Buy MindMed (MNMD) - The Motley Fool

Click here to get full coverage on Mind Medicine Nears Pivotal Year: Strong Fundamentals Make It A Buy (NASDAQ:MNMD) - Seeking Alpha

Mind Medicine Nears Pivotal Year: Strong Fundamentals Make It A Buy (NASDAQ:MNMD)  Seeking Alpha

Mind Medicine Nears Pivotal Year: Strong Fundamentals Make It A Buy (NASDAQ:MNMD) - Seeking Alpha

Click here to get full coverage on MIND MEDICINE Earnings Results: $MNMD Reports Quarterly Earnings - Quiver Quantitative

MIND MEDICINE Earnings Results: $MNMD Reports Quarterly Earnings  Quiver Quantitative

MIND MEDICINE Earnings Results: $MNMD Reports Quarterly Earnings - Quiver Quantitative

Click here to get full coverage on A Fresh Look at MindMed (MNMD) Valuation After Breakthrough Phase 2b Results and FDA Recognition - Sahm

A Fresh Look at MindMed (MNMD) Valuation After Breakthrough Phase 2b Results and FDA Recognition  Sahm

A Fresh Look at MindMed (MNMD) Valuation After Breakthrough Phase 2b Results and FDA Recognition - Sahm

Click here to get full coverage on MindMed Announces New Employee Inducement Grant - Business Wire

MindMed Announces New Employee Inducement Grant  Business Wire

MindMed Announces New Employee Inducement Grant - Business Wire

Click here to get full coverage on Assessing MindMed (MNMD) Valuation Following $225 Million Capital Raise and New Growth Plans - Sahm

Assessing MindMed (MNMD) Valuation Following $225 Million Capital Raise and New Growth Plans  Sahm

Assessing MindMed (MNMD) Valuation Following $225 Million Capital Raise and New Growth Plans - Sahm

Click here to get full coverage on Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) Q3 2025 Earnings Call Transcript - Insider Monkey

Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) Q3 2025 Earnings Call Transcript  Insider Monkey

Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) Q3 2025 Earnings Call Transcript - Insider Monkey

Click here to get full coverage on Mind Medicine (MindMed) Inc. (MNMD) Stock Analysis: Exploring a Promising 90% Upside Potential - DirectorsTalk Interviews

Mind Medicine (MindMed) Inc. (MNMD) Stock Analysis: Exploring a Promising 90% Upside Potential  DirectorsTalk Interviews

Mind Medicine (MindMed) Inc. (MNMD) Stock Analysis: Exploring a Promising 90% Upside Potential - DirectorsTalk Interviews

Click here to get full coverage on Mind Medicine (MindMed) Inc. (MNMD): Analysts See 285% Upside Potential - Yahoo Finance

Mind Medicine (MindMed) Inc. (MNMD): Analysts See 285% Upside Potential  Yahoo Finance

Mind Medicine (MindMed) Inc. (MNMD): Analysts See 285% Upside Potential - Yahoo Finance

Click here to get full coverage on Psychedelics Break Out Of The Fringe Under RFK Jr’s 2025 Reset — But Did MNMD Or CMPS Own The Year? - Stocktwits

Psychedelics Break Out Of The Fringe Under RFK Jr’s 2025 Reset — But Did MNMD Or CMPS Own The Year?  Stocktwits

Psychedelics Break Out Of The Fringe Under RFK Jr’s 2025 Reset — But Did MNMD Or CMPS Own The Year? - Stocktwits

Click here to get full coverage on Mind Medicine (MindMed) Inc. (MNMD) Stock Analysis: Exploring a Robust 152% Potential Upside - DirectorsTalk Interviews

Mind Medicine (MindMed) Inc. (MNMD) Stock Analysis: Exploring a Robust 152% Potential Upside  DirectorsTalk Interviews

Mind Medicine (MindMed) Inc. (MNMD) Stock Analysis: Exploring a Robust 152% Potential Upside - DirectorsTalk Interviews

Click here to get full coverage on Mind Medicine (MindMed) Inc. Announces Closing of Approximately $259 Million Public Offering, Including Full Exercise of the Underwriters’ Option to Purchase Additional Shares - Business Wire

Mind Medicine (MindMed) Inc. Announces Closing of Approximately $259 Million Public Offering, Including Full Exercise of the Underwriters’ Option to Purchase Additional Shares  Business Wire

Mind Medicine (MindMed) Inc. Announces Closing of Approximately $259 Million Public Offering, Including Full Exercise of the Underwriters’ Option to Purchase Additional Shares - Business Wire

Click here to get full coverage on Mind Medicine: Heading In The Right Direction (NASDAQ:MNMD) - Seeking Alpha

Mind Medicine: Heading In The Right Direction (NASDAQ:MNMD)  Seeking Alpha

Mind Medicine: Heading In The Right Direction (NASDAQ:MNMD) - Seeking Alpha

Click here to get full coverage on Mind Medicine (MindMed) Inc. Announces Pricing of $225 Million Public Offering - Business Wire

Mind Medicine (MindMed) Inc. Announces Pricing of $225 Million Public Offering  Business Wire

Mind Medicine (MindMed) Inc. Announces Pricing of $225 Million Public Offering - Business Wire

Click here to get full coverage on Definium Therapeutics (MNMD) Announces Rebranding and Ticker Cha - GuruFocus

Definium Therapeutics (MNMD) Announces Rebranding and Ticker Cha  GuruFocus

Definium Therapeutics (MNMD) Announces Rebranding and Ticker Cha - GuruFocus

Click here to get full coverage on Jones Trading Initiates Coverage on Mind Medicine (MNMD) with 'B - GuruFocus

Jones Trading Initiates Coverage on Mind Medicine (MNMD) with 'B  GuruFocus

Jones Trading Initiates Coverage on Mind Medicine (MNMD) with 'B - GuruFocus

Click here to get full coverage on Mind Medicine Completes Successful Public Offering - TipRanks

Mind Medicine Completes Successful Public Offering  TipRanks

Mind Medicine Completes Successful Public Offering - TipRanks

Click here to get full coverage on Is Mind Medicine stock a buy? - Cantech Letter

Is Mind Medicine stock a buy?  Cantech Letter

Is Mind Medicine stock a buy? - Cantech Letter

Click here to get full coverage on MindMed dips after $225 mln stock deal - TradingView

MindMed dips after $225 mln stock deal  TradingView

MindMed dips after $225 mln stock deal - TradingView

Click here to get full coverage on Was Jim Cramer Right About Mind Medicine (MNMD) Stock? - Yahoo Finance

Was Jim Cramer Right About Mind Medicine (MNMD) Stock?  Yahoo Finance

Was Jim Cramer Right About Mind Medicine (MNMD) Stock? - Yahoo Finance

Click here to get full coverage on Mind Medicine (MNMD) Projected to Shine in 2026 with Promising D - GuruFocus

Mind Medicine (MNMD) Projected to Shine in 2026 with Promising D  GuruFocus

Mind Medicine (MNMD) Projected to Shine in 2026 with Promising D - GuruFocus

Click here to get full coverage on 5 High-Risk, High-Reward Biotech Breakthrough Stocks to Watch in 2026 - The Globe and Mail

5 High-Risk, High-Reward Biotech Breakthrough Stocks to Watch in 2026  The Globe and Mail

5 High-Risk, High-Reward Biotech Breakthrough Stocks to Watch in 2026 - The Globe and Mail

Click here to get full coverage on Definium Therapeutics Rebrands and Highlights 2026 Pipeline - TipRanks

Definium Therapeutics Rebrands and Highlights 2026 Pipeline  TipRanks

Definium Therapeutics Rebrands and Highlights 2026 Pipeline - TipRanks

Click here to get full coverage on MindMed Issues Inducement Grants to New Employees - TipRanks

MindMed Issues Inducement Grants to New Employees  TipRanks

MindMed Issues Inducement Grants to New Employees - TipRanks

Click here to get full coverage on Mind Medicine (MindMed) Inc. (MNMD) Stock Analysis: A Potential 235% Upside in the Biotech Sector - DirectorsTalk Interviews

Mind Medicine (MindMed) Inc. (MNMD) Stock Analysis: A Potential 235% Upside in the Biotech Sector  DirectorsTalk Interviews

Mind Medicine (MindMed) Inc. (MNMD) Stock Analysis: A Potential 235% Upside in the Biotech Sector - DirectorsTalk Interviews

Click here to get full coverage on A Quick Look at Today's Ratings for Mind Medicine(MNMD.US), With a Forecast Between $25 to $32 - 富途牛牛

A Quick Look at Today's Ratings for Mind Medicine(MNMD.US), With a Forecast Between $25 to $32  富途牛牛

A Quick Look at Today's Ratings for Mind Medicine(MNMD.US), With a Forecast Between $25 to $32 - 富途牛牛

Click here to get full coverage on Mind Medicine (MindMed) Inc. (MNMD) Stock Analysis: Exploring a Potential 135% Upside for Biotech Investors - DirectorsTalk Interviews

Mind Medicine (MindMed) Inc. (MNMD) Stock Analysis: Exploring a Potential 135% Upside for Biotech Investors  DirectorsTalk Interviews

Mind Medicine (MindMed) Inc. (MNMD) Stock Analysis: Exploring a Potential 135% Upside for Biotech Investors - DirectorsTalk Interviews

Click here to get full coverage on Is Mind Medicine (MNMD) the Best Multibagger Stock to Buy Heading into 2025? - Yahoo Finance

Is Mind Medicine (MNMD) the Best Multibagger Stock to Buy Heading into 2025?  Yahoo Finance

Is Mind Medicine (MNMD) the Best Multibagger Stock to Buy Heading into 2025? - Yahoo Finance

Click here to get full coverage on Institutional investors own a significant stake of 50% in Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) - Yahoo Finance

Institutional investors own a significant stake of 50% in Mind Medicine (MindMed) Inc. (NASDAQ:MNMD)  Yahoo Finance

Institutional investors own a significant stake of 50% in Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) - Yahoo Finance

Click here to get full coverage on Maxim Group Maintains Mind Medicine(MNMD.US) With Buy Rating, Maintains Target Price $18 - 富途牛牛

Maxim Group Maintains Mind Medicine(MNMD.US) With Buy Rating, Maintains Target Price $18  富途牛牛

Maxim Group Maintains Mind Medicine(MNMD.US) With Buy Rating, Maintains Target Price $18 - 富途牛牛

Click here to get full coverage on MindMed Strengthens Executive Team with Appointment of Brandi Roberts, CPA, as Chief Financial Officer - Business Wire

MindMed Strengthens Executive Team with Appointment of Brandi Roberts, CPA, as Chief Financial Officer  Business Wire

MindMed Strengthens Executive Team with Appointment of Brandi Roberts, CPA, as Chief Financial Officer - Business Wire

Click here to get full coverage on MindMed (MNMD) Stock Rises 154% in 3 Months: Here's Why - Yahoo Finance

MindMed (MNMD) Stock Rises 154% in 3 Months: Here's Why  Yahoo Finance

MindMed (MNMD) Stock Rises 154% in 3 Months: Here's Why - Yahoo Finance

Click here to get full coverage on MNMD Technical Analysis | Trend, Signals & Chart Patterns | MIND MEDICINE MINDMED INC (NASDAQ:MNMD) - ChartMill

MNMD Technical Analysis | Trend, Signals & Chart Patterns | MIND MEDICINE MINDMED INC (NASDAQ:MNMD)  ChartMill

MNMD Technical Analysis | Trend, Signals & Chart Patterns | MIND MEDICINE MINDMED INC (NASDAQ:MNMD) - ChartMill

Click here to get full coverage on Mind Medicine (MindMed) Inc. (MNMD): Among the Best Psychedelic Stocks to Buy in 2025 - Yahoo Finance

Mind Medicine (MindMed) Inc. (MNMD): Among the Best Psychedelic Stocks to Buy in 2025  Yahoo Finance

Mind Medicine (MindMed) Inc. (MNMD): Among the Best Psychedelic Stocks to Buy in 2025 - Yahoo Finance

Click here to get full coverage on MindMed Reports First Quarter 2025 Financial Results and Recent Business Updates - Business Wire

MindMed Reports First Quarter 2025 Financial Results and Recent Business Updates  Business Wire

MNMD

Price Chart

Key Statistics

Technicals

About MNMD

Latest News

MNMD Stock Up More Than 100% in 6 Months: What's in Store for 2026? - Yahoo Finance

Mind Medicine Inc. (MNMD) Stock Analysis: Exploring Potential Upside in a Transformative Biotech - DirectorsTalk Interviews

$MNMD stock is down 10% today. Here's what we see in our data. - Quiver Quantitative

Advanced Charts

Top Gainers

Top Losers